Cargando…
Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study
BACKGROUND: Kallikrein-8 (KLK8) might be an early blood-biomarker of Alzheimer’s disease (AD). We examined whether blood KLK8 is elevated in persons with amnestic mild cognitive impairment (aMCI) which is a precursor of AD, compared to cognitively unimpaired (CU) controls. METHODS: Forty cases and 8...
Autores principales: | Schramm, Sara, Jokisch, Martha, Jöckel, Karl-Heinz, Herring, Arne, Keyvani, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690879/ https://www.ncbi.nlm.nih.gov/pubmed/34930454 http://dx.doi.org/10.1186/s13195-021-00945-x |
Ejemplares similares
-
Blood Kallikrein-8 and Non-Amnestic Mild Cognitive Impairment: An Exploratory Study
por: Schramm, Sara, et al.
Publicado: (2023) -
Fluctuation of depressive symptoms in cognitively unimpaired participants and the risk of mild cognitive impairment 5 years later: Results of the Heinz Nixdorf Recall study
por: Jokisch, Martha, et al.
Publicado: (2022) -
Interaction of Alzheimer’s Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study
por: Frank, Mirjam, et al.
Publicado: (2021) -
Associations between self-reported sleep characteristics and incident mild cognitive impairment: The Heinz Nixdorf Recall Cohort Study
por: Brachem, Christian, et al.
Publicado: (2020) -
Family aggregation of sleep characteristics: Results of the Heinz Nixdorf Recall and the Multi-Generation Study
por: Kowall, Bernd, et al.
Publicado: (2021)